Abstract:The purpose of the present study was to elucidate the effects of cyclooxygenase 2 (COX-2) on the expression of vascular endothelial growth factor (VEGF) and prostaglandin E-2 (PGE(2)) in pancreatic cancer in vitro and in vivo, and to clarify the potential mechanism of COX-2-induced angiogenesis of pancreatic cancer. The study analysis was conducted in the pancreatic cancer PC-3 cell line. The expression of COX-2 and VEGF in human pancreatic cancer tissue was analyzed by immunohistochemistry. Angiogenesis was detected using immunohistochemistry with anti-collagen IV antibodies, and was calculated according to the microvascular density (MVD). In vitro analysis was performed using ELISA or radioimmunoassay (RIA). The effect of exogenous PGE(2) on the downregulation of VEGF by Celebrex was also assessed. In vivo analysis was performed using western blotting or RIA. Concurrently, MVD was also investigated in nude mice using immunohistochemistry with anti-collagen IV antibodies. COX-2 was overexpressed in pancreatic cancer tissues, with an overall positive rate of 87.5%. There was a positive association between the expression of COX-2 and MVD. The in vitro study indicated that Celebrex suppressed the expression of VEGF and PGE(2) in PC-3 cells in a dose- and time-dependent manner, while exogenous PGE(2) rescued the expression of VEGF, which was suppressed by Celebrex, in a dose-dependent manner. The in vivo study revealed that the administration of Celebrex to xenograft nude mice significantly inhibited the expression of VEGF and PGE(2). These data provide evidence that PGE2 may he an important mediator between COX-2 and VEGF expression in the process of angiogenesis in pancreatic cancer.

Effect of Celebrex on the Apoptosis and VEGF Expression of PC12 Cells

[Effect of Selective Cyclooxygenase-2 Inhibitor Celebrex on Expression of Vascular Endothelial Growth Factor (VEGF) in Pancreatic Carcinoma].

Impact of the Selective Cyclooxygenase-2 Inhibitor Celebrex on Angiogenesis in Pancreatic Carcinoma

Inhibitory Effects of Epigallocatechin Gallate (EGCG) and Cd2+ on the Growth of Prostate Cancer PC-3 Cell

Apoptosis Induced by Celecoxib Eombinated with Cisplatin in Human Osteosarcoma Cell Line MG-63 Via Down-Regulation of PI3K/Akt

Cyclooxygenase-2 Induces Angiogenesis in Pancreatic Cancer Mediated by Prostaglandin E-2

Celecoxib in the Histological Grade of Chemically Induced Mammary Tumor in Rats

Effects of Celecoxib on the proliferation and apoptosis of hepatocellular carcinoma cell line SMMC-7721Cells through ERK1/2 pathway

Effect of celecoxib on hepatic and renal functions in rats with mammary carcinoma

Sbudies on the Effect of Parthenolide on the Proliferation of Rat Vascular Smooth Muscle Cells and the Mechanism

Inhibitory Effect of a Non-Steroidal Anti-Inflammatory Drug,celecoxib,on Angiogenesis in Lung Cancer

Effect of Celecoxib on Proliferation, Moving and Invasiveness of Glioma Cells

Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3]

Experimental Study on Inhibitive Effect of a Non-Steroidal Anti-Inflammatory Drug,celecoxib,on Lung Adenocarcinoma

Inhibition of Proliferation and Induction of Apoptosis of Acute Promyelocytic Leukemia Cell Line NB4 by Celecoxib

Effect of Parthenolide on Proliferation and Apoptosis of Human Pancreatic BxPC-3 Cells

Celecoxib Alleviates Radiation-Induced Brain Injury in Rats by Maintaining the Integrity of Blood-Brain Barrier

Effect of Inhibiting Cyclooxygenase-2 Expression on Glioma Immune Microenvironment and Biological Behavior

THE INHIBITORY EFFECT OF CELECOXIB ON LUNG CANCER CELL LINE IN VITRO

Effect of Celecoxib on Proliferation, Collagen Expression, ERK1/2 and SMAD2/3 Phosphorylation in NIH/3T3 Fibroblasts

Effects of cyclooxygenase-2 inhibitor on proliferation and apoptosis of C6 glioma cells